Thermo Fisher Scientific Expands GMP Laboratory Service Offerings with Biosafety Testing Including Mycoplasma Testing

WILMINGTON, N.C., February 13, 2024--Thermo Fisher Scientific’s PPD clinical research business adding mycoplasma and additional biosafety testing capabilities at Wisconsin GMP lab

Related Keywords

Wisconsin ,United States ,Kentucky ,Virginia ,Athlone ,Westmeath ,Ireland ,China ,Richmond ,Singapore ,Belgium ,Suzhou ,Jiangsu ,Brussels ,Bruxelles Capitale ,Highland Heights ,Sebastian Pacios ,Randy Buckwalter ,Our Mission ,Thermo Fisher ,Fisher Scientific ,Unity Lab Services ,Thermo Fisher Scientific Inc ,Thermo Scientific ,Applied Biosystems ,Contact Information ,Thermo Fisher Scientific ,Mp Guidelines ,Mp ,Stability Testing ,Testing Service ,Biopharmaceutical Products ,Nucleic Acid Testing ,Mammalian Cell Cultures ,Clinical Research ,Pharmaceutical Services ,